{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:50:28Z","timestamp":1775555428675,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Exper.Med."],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s10238-008-0149-z","type":"journal-article","created":{"date-parts":[[2008,4,2]],"date-time":"2008-04-02T16:21:25Z","timestamp":1207153285000},"page":"1-7","source":"Crossref","is-referenced-by-count":24,"title":["Characterisation of TNF-related apoptosis-inducing ligand in peripheral blood in patients with primary biliary cirrhosis"],"prefix":"10.1007","volume":"8","author":[{"given":"Yan","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaixing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renqian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,3]]},"reference":[{"key":"149_CR1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00795-006-0321-z","volume":"39","author":"K. Harada","year":"2006","unstructured":"Harada K, Nakanuma Y (2006) Molecular mechanisms of cholangiopathy in primary biliary cirrhosis. Med Mol Morphol 39:55\u201361","journal-title":"Med Mol Morphol"},{"key":"149_CR2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.0106-9543.2002.01595.x","volume":"22","author":"J. Tinmouth","year":"2002","unstructured":"Tinmouth J, Lee M, Wanless IR et al (2002) Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Liver 22:228\u2013234","journal-title":"Liver"},{"key":"149_CR3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0046-8177(00)80217-8","volume":"31","author":"M. Iwata","year":"2000","unstructured":"Iwata M, Harada K, Kono N et al (2000) Expression of Bcl-2 familial proteins is reduced in small bile duct lesions of primary biliary cirrhosis. Hum Pathol 31:179\u2013184","journal-title":"Hum Pathol"},{"key":"149_CR4","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.510260604","volume":"26","author":"K. Harada","year":"1997","unstructured":"Harada K, Ozaki S, Gershwin ME et al (1997) Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology 26:1399\u20131405","journal-title":"Hepatology"},{"key":"149_CR5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","volume":"3","author":"S.R. Wiley","year":"1995","unstructured":"Wiley SR, Schooley K, Smolak PJ et al (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673\u2013682","journal-title":"Immunity"},{"key":"149_CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.cdd.4401187","volume":"10","author":"H.N. LeBlanc","year":"2003","unstructured":"LeBlanc HN, Ashkenazi A (2003) Apo 2L\/TRAIL and its death and decoy receptors. Cell Death Differ 10:66\u201375","journal-title":"Cell Death Differ"},{"key":"149_CR7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clim.2005.05.001","volume":"117","author":"V. Rus","year":"2005","unstructured":"Rus V, Zernetkina V, Puliaev R et al (2005) Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease. Clin Immunol 117:48\u201356","journal-title":"Clin Immunol"},{"key":"149_CR8","first-page":"113","volume":"2","author":"Y. Huang","year":"2005","unstructured":"Huang Y, Erdmann N, Peng H et al (2005) The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases. Cell Mol Immunol 2:113\u2013122","journal-title":"Cell Mol Immunol"},{"key":"149_CR9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1440-1711.2005.01358.x","volume":"83","author":"E. Cretney","year":"2005","unstructured":"Cretney E, McQualter JL, Kayagaki N et al (2005) TNF-related apoptosis-inducing ligand (TRAIL)\/Apo2L suppresses experimental autoimmune encephalomyelitis in mice. Immunol Cell Biol 83:511\u2013519","journal-title":"Immunol Cell Biol"},{"key":"149_CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.trsl.2006.04.007","volume":"148","author":"N. Baba","year":"2006","unstructured":"Baba N, Kobashi H, Yamamoto K et al (2006) Gene expression profiling in biliary epithelial cells of primary biliary cirrhosis using laser capture microdissection and cDNA microarray. Translational Res 148:103\u2013113","journal-title":"Translational Res"},{"key":"149_CR11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2249.2006.03293.x","volume":"148","author":"N. Pelli","year":"2007","unstructured":"Pelli N, Floreani A, Torre F et al (2007) Soluble apoptosis molecules in primary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C. Clin Exp Immunol 148:85\u201389","journal-title":"Clin Exp Immunol"},{"key":"149_CR12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1053\/he.2000.5984","volume":"31","author":"E.J. Heathcote","year":"2000","unstructured":"Heathcote EJ (2000) Management of primary biliary cirrhosis. Hepatology 31:1005\u20131013","journal-title":"Hepatology"},{"key":"149_CR13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/75045","volume":"6","author":"M. Jo","year":"2000","unstructured":"Jo M, Kim TH, Seol DW et al (2000) Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6:564\u2013567","journal-title":"Nat Med"},{"key":"149_CR14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1124\/jpet.102.040030","volume":"303","author":"H. Higuchi","year":"2002","unstructured":"Higuchi H, Bronk SF, Taniai M et al (2002) Cholestasis increases tumor necrosis factor-related apoptosis-inducing ligand(TRAIL)-R2\/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity. J Pharmacol Exp Ther 303:461\u2013467","journal-title":"J Pharmacol Exp Ther"},{"key":"149_CR15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2036.2000.00729.x","volume":"14","author":"A. Floreani","year":"2000","unstructured":"Floreani A, Baragiotta A, Martines D et al (2000) Plasma antioxidant levels in chronic cholestatic liver diseases. Aliment Pharmacol Ther 14:353\u2013358","journal-title":"Aliment Pharmacol Ther"},{"key":"149_CR16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0168-8278(03)00265-4","volume":"39","author":"H.L. Janssen","year":"2003","unstructured":"Janssen HL, Higuchi H, Abdulkarim A et al (2003) Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)cytotoxicity by increasing TRAIL-R1\/death receptor 4 expression. J Hepatol 39:414\u2013420","journal-title":"J Hepatol"},{"key":"149_CR17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4049\/jimmunol.178.1.503","volume":"178","author":"X. Liang","year":"2007","unstructured":"Liang X, Liu Y, Zhang Q et al (2007) Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. J Immunol 178:503\u2013510","journal-title":"J Immunol"},{"key":"149_CR18","doi-asserted-by":"crossref","first-page":"38610","DOI":"10.1074\/jbc.M105300200","volume":"276","author":"H. Higuchi","year":"2001","unstructured":"Higuchi H, Bronk SF, Takikawa Y et al (2001) The bile acid glycochenodeoxycholate induces trail-receptor 2\/DR5 expression and apoptosis. J Biol Chem 276:38610\u201338618","journal-title":"J Biol Chem"},{"key":"149_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1074\/jbc.M309476200","volume":"279","author":"H. Higuchi","year":"2004","unstructured":"Higuchi H, Grambihler A, Canbay A et al (2004) Bile acids upregulate death receptor 5\/TRAIL-receptor 2 expression via a c-jun N-terminal kinase-dependent pathway involving Sp1. J Biol Chem 279:51\u201360","journal-title":"J Biol Chem"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-008-0149-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-008-0149-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-008-0149-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T11:37:32Z","timestamp":1559129852000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-008-0149-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["149"],"URL":"https:\/\/doi.org\/10.1007\/s10238-008-0149-z","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}